Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG

Approved

STANDARD

SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG

Egis Pharmaceuticals Plc.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 17, 2021
Approval ID: e3cb6978839e4df3
Company: Egis Pharmaceuticals Plc.
Type: Standard

Approval Details

Approval Id: e3cb6978839e4df3
Drug Cima Aemps Name: SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG
Register Number: 86031
Holder Company Name: Egis Pharmaceuticals Plc.
Marketing Company Name: Egis Pharmaceuticals Plc.
Authorization Date: 2021-06-17
Dosage Form: CÁPSULA DURA
Dose: 12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Egis Pharmaceuticals Plc.

Active Ingredients

SUNITINIB CICLAMATO

18,12 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 17, 2021

Approval ID

e3cb6978839e4df3

Type

Standard

Back to CIMA-AEMPS Approvals